Overcoming HIV latency is a major step toward creating a cure for HIV. For the first time, scientists at Carolina, Emory University and Qura Therapeutics – a partnership between Carolina and ViiV Healthcare – have found a new approach that can expose latent HIV.
Overcoming HIV latency is a major step toward creating a cure for HIV. For the first time, scientists at Carolina, Emory University and Qura Therapeutics – a partnership between Carolina and ViiV Healthcare – have found a new approach that can expose latent HIV.
UNC-Chapel Hill researchers examined how negative media coverage of the HPV vaccine impacted vaccination rates in Denmark to better understand the damage misinformation causes.
Blood clot expert Dr. Stephan Moll, professor of medicine in the School of Medicine, consulted NASA on how to treat a U.S. astronaut’s deep vein thrombosis during a mission on the International Space Station.
An alliance between UNC-Chapel Hill and Deerfield Management Company intends to advance Carolina innovations toward a possible new treatment against a devastating cancer.
Carolina researcher Barry Popkin finds that major food system changes have led the poorest countries to have high levels of overweight and obesity along with undernutrition.
Led by J. Victor Garcia, biomedical researchers have begun a three-year project funded by the Bill & Melinda Gates Foundation to develop and implement an effective ultra-long-acting antiviral delivery system to combat the spread of HIV.
